Combined use of lysyl oxidase, carcino-embryonic antigen, and carbohydrate antigens improves the sensitivity of biomarkers in predicting lymph node metastasis and peritoneal metastasis in gastric cancer. The gene discussed is CEACAM5; the disease is metastatic malignant neoplasm in the lymph nodes.